Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>: Combination drug therapy has become an effective strategy for inflammation control. The anti‑inflammatory capacities of silibinin and thymol have each been investigated on its own, but little is known about the synergistic anti-inflammatory effects of these two compounds.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Purpose</h3><p>: This study aims to investigate the synergistic anti-inflammatory effects of silibinin and thymol when administered in combination to lipopolysaccharide (LPS)-induced RAW264.7 cells.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>: RAW264.7 cells were pre-treated with silibinin and thymol individually or in combination for 2 h before LPS stimulation. Cell viability was detected by the MTT assay. Nitric oxide (NO) production was measured by Griess reagent. Reactive oxygen species (ROS) was evaluated by 2',7'-dichlorofluorescein-diacetate. ELISA was used to detect tumour necrosis factor-α (TNF-α), and interleukin-6 (IL-6). Western blot was performed to analyse the protein expression of LPS-induced RAW264.7 cells.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>: We observed a synergistic anti-inflammatory effect of silibinin and thymol when administered in combination to LPS-induced RAW264.7 cells. Silibinin combined with thymol (40 μM and 120 μM respectively, with the molar ratio 1:3) had more potent effects on the inhibition of NO, TNF-α, and IL-6 than those exerted by individual administration of these compounds in LPS-induced RAW264.7 cells. The combination of silibinin and thymol (40 μM and 120 μM respectively, with the molar ratio 1:3) strongly inhibited ROS and cyclooxygenase-2 (COX-2). More importantly, the combination of silibinin and thymol (40 μM and 120 μM respectively, with the molar ratio 1:3) was also successful in inhibiting nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) activities. Our results suggest that the synergistic anti-inflammatory effects of silibinin with thymol were associated with the inhibition of NF-κB and MAPK signalling pathways.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>: The combination of silibinin and thymol (40 μM and 120 μM respectively, with the molar ratio 1:3) could inhibit inflammation by suppressing NF-κB and MAPK signalling pathways in LPS-induced RAW264.7 cells.</p>

Two methoxy derivatives of resveratrol, 3,3',4,5'-tetramethoxy-trans-stilbene and 3,4',5-trimethoxy-trans-stilbene, suppress lipopolysaccharide-induced inflammation through inactivation of MAPK and NF-κB pathways in RAW 264.7 cells

Anti-inflammatory Effects of Ganoderma Lucidum Sterols Via Attenuation of the P38 MAPK and NF-κB Pathways in LPS-induced RAW 264.7 Macrophages

Synergistic Anti-Inflammatory Effects of Resveratrol and Vitamin E in Lipopolysaccharide-Induced RAW264.7 Cells

Effects of Selected Resveratrol Analogues on Activation and Polarization of Lipopolysaccharide-Stimulated BV-2 Microglial Cells

Resveratrol Reduces the Proinflammatory Effects and Lipopolysaccharide- Induced Expression of HMGB1 and TLR4 in RAW264.7 Cells

Thymol Mitigates Lipopolysaccharide-Induced Endometritis by Regulating the TLR4- and ROS-mediated NF-κB Signaling Pathways

Resveratrol mitigates lipopolysaccharide-mediated acute inflammation in rats by inhibiting the TLR4/NF-κBp65/MAPKs signaling cascade

Resveratrol Inhibits LPS‑induced Inflammation Through Suppressing the Signaling Cascades of TLR4‑NF‑κB/MAPKs/IRF3

HO-1 is Essential for Tetrahydroxystilbene Glucoside Mediated Mitochondrial Biogenesis and Anti-Inflammation Process in LPS-Treated RAW264.7 Macrophages

Effects of Resveratrol and Its Derivatives on Lipopolysaccharide-Induced Microglial Activation and Their Structure-Activity Relationships.

The Anti-Inflammatory Effect of Ent-Kaur-15-en-17-al-18-oic Acid on Lipopolysaccharide-Stimulated RAW264.7 Cells Associated with NF-κB and P38/MAPK Pathways.

Resveratrol attenuates inflammation by regulating macrophage polarization via inhibition of toll-like receptor 4/MyD88 signaling pathway

Microbe-Derived Antioxidants Reduce Lipopolysaccharide-Induced Inflammatory Responses by Activating the Nrf2 Pathway to Inhibit the ROS/NLRP3/IL-1 Signaling Pathway

Stevioside Suppressed Inflammatory Cytokine Secretion by Downregulation of NF-κB and MAPK Signaling Pathways in LPS-Stimulated RAW264.7 Cells

Quercetin and Quercitrin Attenuates the Inflammatory Response and Oxidative Stress in LPS-Induced RAW264.7 Cells: In Vitro Assessment and a Theoretical Model

Anti-Inflammatory Property of 5-Demethylnobiletin (5-Hydroxy-6, 7, 8, 3′, 4′-pentamethoxyflavone) and Its Metabolites in Lipopolysaccharide (LPS)-Induced RAW 264.7 Cells

TSG (2,3,4' ,5-Tetrahydroxystilbene 2-O-β-d-glucoside) Suppresses Induction of Pro-Inflammatory Factors by Attenuating the Binding Activity of Nuclear Factor-Κb in Microglia.

Tsg (2,3,4 ', 5-Tetrahydroxystilbene 2-O Beta-D- Glucoside) Suppresses Induction Of Pro-Inflammatory Factors By Attenuating The Binding Activity Of Nuclear Factor-.B In Microglia

Synergistic anti-inflammatory effects of silibinin and thymol combination on LPS-induced RAW264.7 cells by inhibition of NF-κB and MAPK activation

Inhibitory Effect of Resveratrol Dimerized Derivatives on Nitric Oxide Production in Lipopolysaccharide-Induced Raw 264.7 Cells

Resokaempferol-mediated Anti-Inflammatory Effects on Activated Macrophages Via the Inhibition of JAK2/STAT3, NF-κB and JNK/p38 MAPK Signaling Pathways.